Original news and analysis on international IP policy
Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably.
The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments.
Today the World Health Organization released its first set of surveillance data on antibiotic resistance. The data shows that resistance to antibiotics is growing among the world's most common bacteria, in both high- and low-income countries. Industry announced that it is in the process of making its surveillance data available.
In a recent decision, the Appeal Board of Japan Patent Office (JPO) refused to register trademark application no. 2015- 100245 for a red-colored word mark “ROMEO GIGLI” in gothic script (see below) designating goods of Class 24 and 25 on the grounds that applicant failed to obtain a consent from Italian fashion designer, Romeo Gigli, based on Article 4(1)(viii) of the Trademark Law, writes Masaki Mikami.
One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes.
Member nations of the World Health Organization became accustomed in recent years to singing by the WHO director general, and sometimes crying, but under the new DG there seems to be a move toward the whole room getting up in the middle of serious negotiations and ... dancing.
After long deliberations, the World Health Organization Executive Board agreed this morning to ask member states and the organisation to implement recommendations aiming at improving innovation and access to medicines. Three recommendations, specifically aimed at member states, including on the transparency on the cost of research and development of medicines, met resistance by some countries and were left hanging, to be discussed by member states with no timeframe.
The UN Convention on Biological Diversity has issued the results of a fact-finding study on genetic resources digital genetic information. The study particularly examined terminology and how digital genetic information are influencing its protocol on access and benefit sharing of genetic resources. The study called for policymakers to stay abreast of the profound developments shaping research today, and underlined challenges such as the identification of contributors and users, the provenance of sequences, and what the study defined as a "grey area" between non-commercial and commercial research.
The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property.
The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions.